首页|当归芍药散治疗慢性盆腔炎的临床研究及实验研究进展

当归芍药散治疗慢性盆腔炎的临床研究及实验研究进展

扫码查看
慢性盆腔炎(CPID)是女性常见的慢性炎症性疾病,具有病程长、易复发的特点.当归芍药散出自《金匮要略》,为治疗"妇人腹中诸疾痛"的常用方,现代常用于治疗CPID,并取得较好疗效.该文对近10年来当归芍药散治疗CPID的临床研究和实验研究方面的文献进行总结分析,探讨当归芍药散治疗CPID的临床疗效及其作用机制.临床研究方面,应用当归芍药散治疗CPID多使用原方加减用药,或单独使用,或联合抗生素及中医外治法;与单独应用西药相比,当归芍药散联合西药可明显改善炎症指标及免疫功能指标、缓解疼痛等临床症状与体征,且未增加不良反应.实验研究方面,当归芍药散可通过降低内皮细胞的黏附、调节细胞外基质的降解、改善炎性因子水平、下调核因子κB(NF-κB)通路相关蛋白表达等对CPID发挥治疗作用.
Progress in Clinical Research and Experimental Study of Danggui Shaoyao Powder in the Treatment of Chronic Pelvic Inflammatory Disease
Chronic pelvic inflammatory disease(CPID)is a common chronic inflammatory disease in women,and has a long course and is easy to relapse.Danggui Shaoyao Powder is from Jin Gui Yao Lve(Synopsis of the Golden Chamber),which was a commonly-used formula for the treatment of women's abdominal pain in ancient medical records.It is now often used in the treatment of CPID and has achieved satisfactory therapeutic effect.The article summarizes and analyzes the achievements in the clinical research and experimental study of Danggui Shaoyao Powder in the treatment of CPID over the past 10 years,and invesigates the clinical efficacy of Danggui Shaoyao Powder in the treatment of CPID and its therapeutic mechanism.In the field of clinical studies,Danggui Shaoyao Powder for the treatment of CPID was used by modification,or alone,or in combination with antibiotics and Chinese medicine external treatment,and its combined use was effective on significantly improving the indicators of inflammatory response and immune function,alleviating the clinical signs and symptoms such as pain,and did not increase the incidence of adverse reactions compared with the application of western medicines alone.In the field of experimental studies,Danggui Shaoyao Powder played the therapeutic role in CPID by decreasing the adhesion of endothelial cells,regulating the degradation of extracellular matrix,improving the level of inflammatory factors,and down-regulating the expression of proteins related to the nuclear factor κB(NF-κB)pathway.

Danggui Shaoyao Powderchronic pelvic inflammatory disease(CPID)clinical researchexperimental studyreview

丰子仪、刘家骏、王兰、陈婉莹、黄洁明

展开 >

广州中医药大学,广东广州 510006

广州中医药大学第一附属医院,广东广州 510405

当归芍药散 慢性盆腔炎 临床研究 实验研究 综述

全国名老中医药专家传承工作室建设项目欧阳惠卿传承工作室项目

国中医药办人教函2018119号

2024

广州中医药大学学报
广州中医药大学

广州中医药大学学报

CSTPCD
影响因子:1.055
ISSN:1007-3213
年,卷(期):2024.41(4)
  • 52